Navigation Links
UC Davis researchers discover new drug target for inflammatory disease
Date:9/22/2008

potential drugs that can block the binding process and hopefully the immune response it kicks into overdrive as well."

In the current study, Takada and team evaluated the possibility of integrin binding by sPLA2-IIA using a computer program that predicts how small molecules bind to receptors. They then performed laboratory experiments using human cells to confirm the resulting predictions.

The researchers conducted additional experiments using human leukemia and lymphoma cell lines, because they are known to express integrins, in order to measure changes in the inflammatory response due to sPLA2-IIA-integrin binding. They found an increase in the number of monocytes, which are important first-line defenders for the immune system responsible for attacking foreign substances in the body. At elevated levels, monocytes indicate an overresponsive immune system.

The involvement of integrins to the inflammatory process is of particular interest to study co-author Kit Lam, chief of hematology and oncology with UC Davis Cancer Center.

"These two and other integrins are found on cancer cells," Lam explained. "And inflammation certainly plays a role in the onset, progression and maintenance of certain cancers. This outcome could have a huge impact on our work in finding medications that halt or at least reduce the impact of inflammation on this disease."

Takada and his colleagues will next be working to screen for molecules that block the binding of sPLA2-IIA to integrins and show that this blockage is enough to shut down an unwanted inflammatory response.

"We cannot ignore integrins anymore," Takada said. "More basic research is needed to understand how integrin-binding results in pro-inflammatory signals. We have to continue to better understand the integrin signaling process if we are to find more potential drug targets for the treatment of inflammation."


'/>"/>

Contact: Karen Finney
karen.finney@ucdmc.ucdavis.edu
916-734-9064
University of California - Davis - Health System
Source:Eurekalert

Page: 1 2

Related biology news :

1. UC Davis researchers define characteristics, treatment options for XXYY syndrome
2. UC Davis researcher leads climate-change discovery
3. UC Davis stem researchers demonstrate safety of gene therapy using adult stem cells
4. UC Davis researchers discover how HIV turns food-poisoning into lethal infection
5. UC Davis bird-flu expert calls for changes in early-warning system
6. Pittsburgh researchers identify source of multipotent stem cells with broad regenerative potential
7. U of M researchers identify gene linked to common ailment in labrador retrievers
8. Friendly bacteria protect against type 1 diabetes, Yale researchers find
9. Using novel tool, UD researchers dig through cell trash and find treasure
10. More than skin deep: Theres no such thing as a safe suntan, researchers warn
11. Flatworm helps researchers study stem cells and cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... our planet for more than 4 billion years before ... as many eons more. That suggests they may have ... Aviv University bacteria expert Prof. Eshel Ben-Jacob of the ... grounded in the study of bacteria, presents compelling evidence ... people should not automatically opt for the swine flu ...
(Date:12/16/2009)... 1 GestureTek Inc. today announced ... - a turnkey, portable, plug and play ... entertainment and touring promotions. GestureTek is the ... in camera-enabled gesture recognition technology for interactive ... for quality, the CUBE has TUV, CE, ...
(Date:12/16/2009)... Inc. is pleased to announce it has acquired ... operating as IgeaCare Systems Inc. The newly formed ... leadership and funding. ,, IgeaCare Solutions Inc. has ... Chief Executive Officer. Under his direction, the new ... and support model; fast and accurate delivery times; ...
Breaking Biology News(10 mins):Bacteria wouldn't opt for a swine flu shot 2Bacteria wouldn't opt for a swine flu shot 3GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 3IgeaCare Solutions Inc. Emerges Under New Leadership and Funding 2Pierre S Freeman Adds Book AMORC Unmasked 21 To his Arsenal of Whistleblower Weapons Aimed at Rosicrucian Order 61353 1Pierre S Freeman Adds Book AMORC Unmasked 21 To his Arsenal of Whistleblower Weapons Aimed at Rosicrucian Order 61353 2Pierre S Freeman Adds Book AMORC Unmasked 21 To his Arsenal of Whistleblower Weapons Aimed at Rosicrucian Order 61353 3Alter EatGos Chef Eric Paul to Prepare Recipes at Two Jewel Osco 28R 29 Locations for the March of Dimes During Prematurity Awareness Month 61348 1Alter EatGos Chef Eric Paul to Prepare Recipes at Two Jewel Osco 28R 29 Locations for the March of Dimes During Prematurity Awareness Month 61348 2Alter EatGos Chef Eric Paul to Prepare Recipes at Two Jewel Osco 28R 29 Locations for the March of Dimes During Prematurity Awareness Month 61348 3Lung Cancer Alliance Hails New Mexico Proclamation on Lung Cancer Awareness Month 61343 1Lung Cancer Alliance Hails New Mexico Proclamation on Lung Cancer Awareness Month 61343 2
... look forward to new, novel forms of their favourite ... genetic data which fruit breeders say will help them ... exciting colours and flavours. , Researchers at New Zealand-based ... company Genesis Research and Development Corporation Limited announced today ...
... the National Institute of Environmental Health Sciences (NIEHS), part of ... binge drink early in their pregnancy increase the likelihood that ... researchers found that women who consumed an average of five ... likely than non-drinkers to have an infant with either of ...
... scientists at the National High Magnetic Field Laboratory at ... petroleum companies to locate, analyze and process crude oil ... Marshall, a giant in the field of chemical analysis, ... with a California-based company, Sierra Analytics ( www.MassSpec.com ), ...
Other Biology News:Genetic data promises new future for kiwi fruit 2Genetic data promises new future for kiwi fruit 3Alcohol binges early in pregnancy increase risk of infant oral clefts 2FSU, Magnet Lab researchers license critical petroleum data 2
(Date:12/16/2009)... has what scientists have been asking for! Zap-CHO is a ... and productivity of CHO cells. Developed for scientists seeking maximum ... defined and consistent recombinant CHO supplement. , ... ... Scientists working with CHO cells can now access an informational ...
(Date:12/15/2009)... 15 Epeius Biotechnologies Corporation, an emerging ... gained international validation of the cutting-edge science behind ... scientists around the world rediscovered the Cyclin ... of cancer pathogenesis and disease progression, and thus ... at the NIH National Cancer Institute investigating the ...
(Date:12/15/2009)... 15 Reportlinker.com announces that a ... its catalogue: ,, The Future ... to 2015, Pipeline Analysis and Reimbursement ... ,, Summary ,, The ... Future of Orphan Diseases Therapeutics - Market ...
(Date:12/15/2009)... --The Mosaic Company (NYSE: MOS ) plans ... results and financial tables on Tuesday, January 5, 2010, ... Stock Exchange. Results will be available on Mosaic,s ... host a conference call with presentation slides on Wednesday, ... call will begin at 11:00 a.m. Eastern Standard Time ...
Breaking Biology Technology:Online Video of InVitria's Zap-CHO Helps Scientists Maximize CHO Cell Culture Performance 2Scientists Rediscover Gene Target for Cancer Therapy 2Scientists Rediscover Gene Target for Cancer Therapy 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18Mosaic Announces Second Quarter Fiscal Year 2010 Earnings Release and Conference Call 2
... and MTA: CTIC) management,s presentation at the 11th Annual BIO CEO &,Investor Conference ... at http://www.celltherapeutics.com . , The presentation will take ... for replay after the presentation. , , ... BIO CEO & Investor Conference, ...
... Clinics of Excellence, LLC, the nation,s only physician-driven ... its 62nd comprehensive Evidence-Based Treatment Protocol covering 11 ... 4th Annual Community Oncology Conference today. "Our 200+ ... to launch the protocols across its network in ...
... HARBIN, China, Feb. 6 /PRNewswire-Asia-FirstCall/ -- China Sky ... Company") (Nasdaq: CSKI ), a leading,fully ... Republic of China ("PRC"), today announced that the ... present and conduct,one-on-one meetings at the upcoming Roth ...
Other Biology Technology:Cancer Clinics of Excellence (CCE) Releases 62nd Evidence-Based Treatment Protocol 2China Sky One Medical, Inc. CFO to Present at Roth Conference 2China Sky One Medical, Inc. CFO to Present at Roth Conference 3
... The Label IT siRNA Tracker Intracellular ... provides a straight forward approach to ... your design, in an efficient yet ... experiments. Subcellular localization and functional inhibition ...
... Tracker Intracellular Localization Kit with TransIT-siQUEST ... approach to directly label and deliver ... efficient yet non-destructive manner, for in ... functional inhibition of target gene expression ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ID clarifier: ...
... instrument can be used as a fully ... Manager Software provides the means to record ... instrument. These data can then be copied ... as Microsoft Excel or Lotus 123, or ...
Biology Products: